{"id":747,"date":"2025-09-04T14:00:23","date_gmt":"2025-09-04T21:00:23","guid":{"rendered":"https:\/\/www.adarx.com\/?p=747"},"modified":"2025-09-04T14:00:24","modified_gmt":"2025-09-04T21:00:24","slug":"adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","title":{"rendered":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">SAN DIEGO, Calif. \u00ad\u00ad\u2013 September 4, 2025 \u2013&nbsp;<a href=\"https:\/\/www.adarx.com\/dev\/\">ADARx Pharmaceuticals, Inc.<\/a> (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Dr. Zhen Li, President and CEO, will participate in a fireside chat at 3:20 p.m. EDT.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>About ADARx Pharmaceuticals\u00a0<\/strong><br><a href=\"https:\/\/www.adarx.com\/dev\/\">ADARx Pharmaceuticals, Inc.<\/a> is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide range of therapeutic areas. We have developed technology to control the expression of specific disease drivers with highly selective RNA targeted therapies with the goal of delivering life-changing treatments for patients with urgent unmet medical needs. ADARx is focused on advancing and expanding a deep pipeline of highly potent, durable and selective RNA-targeted therapeutic candidates, developing product candidates for the treatment of complement-mediated, genetic, cardiovascular, thrombosis, central nervous system and metabolic (obesity) diseases. \u00a0In addition to our wholly-owned programs, we have entered into a collaboration and license option agreement with AbbVie\u00a0to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including neuroscience, immunology and oncology. Follow ADARx on <a href=\"https:\/\/www.linkedin.com\/company\/adarx-pharmaceuticals-inc\/\" target=\"_blank\" rel=\"noreferrer noopener\">LinkedIn<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Contacts<\/strong><br>Investors: <a href=\"mailto:ir@adarx.com\">ir@adarx.com<\/a><br>Media: <a href=\"mailto:teri@redhousecomms.com\">teri@redhousecomms.com<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Calif. \u00ad\u00ad\u2013 September 4, 2025 \u2013&nbsp;ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Dr. Zhen Li, President and CEO, will participate in a fireside chat at 3:20 p.m. EDT. About ADARx Pharmaceuticals\u00a0ADARx [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-747","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Calif. \u00ad\u00ad\u2013 September 4, 2025 \u2013&nbsp;ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Dr. Zhen Li, President and CEO, will participate in a fireside chat at 3:20 p.m. EDT. About ADARx Pharmaceuticals\u00a0ADARx [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"ADARx Pharmaceuticals\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T21:00:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T21:00:24+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#\\\/schema\\\/person\\\/31790f93b65593567a6726ca407a0031\"},\"headline\":\"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference\",\"datePublished\":\"2025-09-04T21:00:23+00:00\",\"dateModified\":\"2025-09-04T21:00:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"},\"wordCount\":205,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\",\"name\":\"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\"},\"datePublished\":\"2025-09-04T21:00:23+00:00\",\"dateModified\":\"2025-09-04T21:00:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#\\\/schema\\\/person\\\/31790f93b65593567a6726ca407a0031\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\",\"name\":\"ADARx Pharmaceuticals\",\"description\":\"Providing hope for patients with intractable disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#\\\/schema\\\/person\\\/31790f93b65593567a6726ca407a0031\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.adarx.com\\\/dev\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals","og_description":"SAN DIEGO, Calif. \u00ad\u00ad\u2013 September 4, 2025 \u2013&nbsp;ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Dr. Zhen Li, President and CEO, will participate in a fireside chat at 3:20 p.m. EDT. About ADARx Pharmaceuticals\u00a0ADARx [&hellip;]","og_url":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","og_site_name":"ADARx Pharmaceuticals","article_published_time":"2025-09-04T21:00:23+00:00","article_modified_time":"2025-09-04T21:00:24+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"},"author":{"name":"admin","@id":"https:\/\/www.adarx.com\/dev\/#\/schema\/person\/31790f93b65593567a6726ca407a0031"},"headline":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference","datePublished":"2025-09-04T21:00:23+00:00","dateModified":"2025-09-04T21:00:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"},"wordCount":205,"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","url":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/","name":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - ADARx Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.adarx.com\/dev\/#website"},"datePublished":"2025-09-04T21:00:23+00:00","dateModified":"2025-09-04T21:00:24+00:00","author":{"@id":"https:\/\/www.adarx.com\/dev\/#\/schema\/person\/31790f93b65593567a6726ca407a0031"},"breadcrumb":{"@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.adarx.com\/dev\/adarx-pharmaceuticals-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.adarx.com\/dev\/"},{"@type":"ListItem","position":2,"name":"ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.adarx.com\/dev\/#website","url":"https:\/\/www.adarx.com\/dev\/","name":"ADARx Pharmaceuticals","description":"Providing hope for patients with intractable disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adarx.com\/dev\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.adarx.com\/dev\/#\/schema\/person\/31790f93b65593567a6726ca407a0031","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/82dca50dfde45fa56a258e833d248704e572b0696fdf3e8ee3811447b2faaf1c?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.adarx.com\/dev"]}]}},"_links":{"self":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/posts\/747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/comments?post=747"}],"version-history":[{"count":1,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/posts\/747\/revisions"}],"predecessor-version":[{"id":748,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/posts\/747\/revisions\/748"}],"wp:attachment":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/media?parent=747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/categories?post=747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/tags?post=747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}